Madrigal Pharmaceuticals, Inc. (MDGL)
USD 315.48
(-3.73%)
USD 315.48
(-3.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -324.23 Million | -224.85 Million | -183.91 Million | -157.56 Million | -41.62 Million | -25.5 Million |
| Net Income | -373.63 Million | -295.35 Million | -241.84 Million | -202.24 Million | -83.94 Million | -32.81 Million |
| Depreciation & Amortization | 527 Thousand | 467 Thousand | 405 Thousand | 471 Thousand | 112 Thousand | 96 Thousand |
| Deferred income taxes | -4.21 Million | - | -7.32 Million | -21.83 Million | -24.29 Million | - |
| Stock-based compensation | 49.73 Million | 31.62 Million | 26.87 Million | 20.73 Million | 22.75 Million | 13.48 Million |
| Change in working capital | -3.27 Million | 37.6 Million | 30.65 Million | 23.48 Million | 19.45 Million | -6.28 Million |
| Other non-cash items | 6.62 Million | 797 Thousand | 7.32 Million | 21.83 Million | 24.29 Million | 13.12 Million |
| Investing Cash Flow | -502.52 Million | 206.68 Million | -5.05 Million | 159.78 Million | 30.7 Million | -380.07 Million |
| Investments in PPE | -1.47 Million | -217 Thousand | -209 Thousand | -334 Thousand | -172 Thousand | -22 Thousand |
| Acquisitions | -5.45 Million | -3000.00 | 787 Thousand | 1.92 Million | 3.64 Million | -3.67 Million |
| Investment purchases | -834.43 Million | -143.47 Million | -394.12 Million | -329.34 Million | -619.3 Million | -614.35 Million |
| Sales/Maturities of investments | 333.39 Million | 350.38 Million | 389.27 Million | 489.45 Million | 650.18 Million | 234.3 Million |
| Other Investing Activities | 5.45 Million | 3000.00 | -787 Thousand | -1.92 Million | -3.64 Million | 3.67 Million |
| Financing Cash Flow | 595.11 Million | 313.45 Million | 171.23 Million | 5.08 Million | 235 Thousand | 314.33 Million |
| Debt repayment | -64.63 Million | -49.11 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 530.47 Million | 255.38 Million | 170.2 Million | 4.42 Million | 235 Thousand | 311.82 Million |
| Other Financing Activities | -363 Thousand | 107.18 Million | 1.03 Million | 667 Thousand | 235.00 | 2.51 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 4.21 Million | 2.45 Million | 20.36 Million | -161 Thousand | -1.3 Million | 558 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.48 Million | 35.15 Million | 10.28 Million | 23.64 Million | 20.76 Million | -6.83 Million |
| Cash at beginning of period | 331.54 Million | 36.26 Million | 54 Million | 46.69 Million | 57.37 Million | 148.62 Million |
| Cash at end of period | 99.91 Million | 331.54 Million | 36.26 Million | 54 Million | 46.69 Million | 57.37 Million |
| Capital Expenditure | -1.47 Million | -217 Thousand | -209 Thousand | -334 Thousand | -172 Thousand | -22 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -231.63 Million | 295.28 Million | -17.73 Million | 7.3 Million | -10.68 Million | -91.24 Million |
| Free Cash Flow | -325.7 Million | -225.07 Million | -184.12 Million | -157.89 Million | -41.79 Million | -25.52 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -106.96 Million | -151.97 Million | -147.54 Million | -373.63 Million | -112.19 Million | -98.74 Million |
| Depreciation & Amortization | -160 Thousand | 267 Thousand | 168 Thousand | 527 Thousand | 142 Thousand | 135 Thousand |
| Deferred income taxes | - | - | - | -4.21 Million | -3.63 Million | - |
| Stock-based compensation | 17.89 Million | 24.4 Million | 19.9 Million | 49.73 Million | 14.85 Million | 12.66 Million |
| Change in working capital | 30.45 Million | -8.11 Million | -22.34 Million | -3.27 Million | 16.51 Million | 351 Thousand |
| Other non-cash items | -8.21 Million | 39.16 Million | 33.26 Million | 6.62 Million | 4.39 Million | 674 Thousand |
| Investing Cash Flow | -202.39 Million | -122.09 Million | 98.05 Million | -502.52 Million | -362.12 Million | 50.19 Million |
| Investments in PPE | 4.22 Million | -5.13 Million | -357 Thousand | -1.47 Million | -1.03 Million | -339 Thousand |
| Acquisitions | - | - | - | -5.45 Million | 361.08 Thousand | -50.53 Thousand |
| Investment purchases | -416.03 Million | -280.79 Million | -84.19 Million | -834.43 Million | -474.89 Million | -68.85 Million |
| Sales/Maturities of investments | 203.66 Million | 163.82 Million | 182.6 Million | 333.39 Million | 113.8 Million | 119.39 Million |
| Other Investing Activities | 5.75 Million | -121.96 Million | 98.41 Million | 5.45 Million | -361.08 Thousand | 50.53 Thousand |
| Financing Cash Flow | 7.46 Million | 134.12 Million | 573.7 Million | 595.11 Million | 479.91 Million | 19.58 Million |
| Debt repayment | - | - | - | -64.63 Million | -64.63 Million | -14.92 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -310.31 Million | 134.12 Million | 573.7 Million | 530.47 Million | 479.91 Million | 4.65 Million |
| Other Financing Activities | 317.78 Million | 134.12 Million | 573.7 Million | -363 Thousand | 479.91 Thousand | -75 Thousand |
| Accounts receivables | -23.56 Million | -6.89 Million | - | - | - | - |
| Accounts payables | 36.97 Million | -7.53 Million | -11.51 Million | 4.21 Million | 11.49 Million | -992 Thousand |
| Inventory | -1.64 Million | -6.21 Million | -854 Thousand | - | - | - |
| Other working capital | -2.56 Million | 12.53 Million | -9.97 Million | -7.48 Million | 5.01 Million | 1.34 Million |
| Cash at beginning of period | 499.59 Million | 622.51 Million | 99.91 Million | 331.54 Million | 62.05 Million | 77.19 Million |
| Cash at end of period | 237.68 Million | 499.59 Million | 622.51 Million | 99.91 Million | 99.91 Million | 62.05 Million |
| Capital Expenditure | 4.22 Million | -5.13 Million | -357 Thousand | -1.47 Million | -1.03 Million | -339 Thousand |
| Effect of forex changes on cash | - | - | - | - | -58.05 Million | - |
| Net cash flow / Change in cash | -261.91 Million | -122.92 Million | 522.6 Million | -231.63 Million | 37.86 Million | -15.14 Million |
| Free Cash Flow | -62.76 Million | -140.07 Million | -149.51 Million | -325.7 Million | -80.96 Million | -85.25 Million |
EXAE
ENX
ARKR
DHARMAJ
000926
0IZM